1,188 results on '"Wells, Philip S"'
Search Results
2. Quality and Patient Safety Metrics: Developing a Structured Program for Improving Patient Care in the Department of Medicine at The Ottawa Hospital
3. Antithrombotic Therapy for VTE Disease: Compendium and Review of CHEST Guidelines 2012-2021
4. A deep-learning approach to predict bleeding risk over time in patients on extended anticoagulation therapy
5. Machine learning analysis of bleeding status in venous thromboembolism patients
6. Qualitative experiences, values, and decisional needs of patients with unprovoked venous thromboembolism who suffer bleeding—“This pill will keep you alive tonight”
7. Balancing risks of recurrent venous thromboembolism and bleeding with extended anticoagulation: a decision analysis
8. Thrombophilia gene mutations predict venous thromboembolism in ambulatory cancer patients receiving chemotherapy
9. Accuracy of physicians’ intuitive risk estimation in the diagnostic management of pulmonary embolism: an individual patient data meta-analysis
10. The risk of major bleeding in patients with factor V Leiden or prothrombin G20210A gene mutation while on extended anticoagulant treatment for venous thromboembolism
11. Redefining clinical venous thromboembolism phenotypes: a novel approach using latent class analysis
12. Serial D-dimers after anticoagulant cessation in unprovoked venous thromboembolism: Data from the REVERSE cohort study
13. Predicting major bleeding during extended anticoagulation for unprovoked or weakly provoked venous thromboembolism
14. Long‐term risk of recurrent venous thromboembolism among patients receiving extended oral anticoagulant therapy for first unprovoked venous thromboembolism: A systematic review and meta‐analysis
15. Long‐term risk of recurrent venous thromboembolism after a first contraceptive‐related event: Data from REVERSE cohort study
16. Venous Thromboembolism Prophylaxis in Critically Ill Adults: A Systematic Review and Network Meta-analysis
17. Balancing risks of recurrent venous thromboembolism and bleeding with extended anticoagulation: a decision analysis
18. Qualitative experiences, values, and decisional needs of patients with unprovoked venous thromboembolism who suffer bleeding—“This pill will keep you alive tonight”
19. Antithrombotic Therapy for VTE Disease: Compendium and Review of CHEST Guidelines 2012-2021
20. Thromboprophylaxis for patients with newly diagnosed vs. recurrent cancers: a post-hoc analysis of the avert trial
21. Risk Stratification of Pulmonary Embolism
22. Direct oral anticoagulant for the prevention of thrombosis in ambulatory patients with cancer: A systematic review and meta‐analysis
23. Balancing risks of recurrent venous thromboembolism and bleeding with extended anticoagulation: a decision analysis.
24. Direct oral anticoagulant use in special populations
25. DNA methylation age is associated with an altered hemostatic profile in a multiethnic meta-analysis
26. Serial imaging after pulmonary embolism and correlation with functional limitation at 12 months: Results of the ELOPE Study
27. Ruling out pulmonary embolism across different healthcare settings: A systematic review and individual patient data meta-analysis
28. Risk for Venous Thromboembolism Recurrence Among Rivaroxaban-treated Patients Who Continued Versus Discontinued Therapy: Analyses Among Patients with VTE
29. Timing of anticoagulant re-initiation following intracerebral hemorrhage in mechanical heart valves: Survey of neurosurgeons and thrombosis experts
30. Impact of Anticoagulation on Mortality and Resource Utilization Among Critically Ill Patients With Major Bleeding
31. Impact of Anticoagulation on Mortality and Resource Utilization Among Critically Ill Patients With Major Bleeding
32. Covariate-specific ROC curve analysis can accommodate differences between covariate subgroups in the evaluation of diagnostic accuracy
33. Accuracy of physicians' intuitive risk estimation in the diagnostic management of pulmonary embolism: An Individual Patient Data Meta-Analysis
34. Redefining clinical venous thromboembolism phenotypes: a novel approach using latent class analysis
35. Recurrent venous thromboembolism and bleeding with extended anticoagulation: the VTE-PREDICT risk score
36. Long-term Anticoagulation With Rivaroxaban for Preventing Recurrent VTE: A Benefit-Risk Analysis of EINSTEIN-Extension
37. Recurrent venous thromboembolism in patients with pulmonary embolism and right ventricular dysfunction: a post-hoc analysis of the Hokusai-VTE study
38. DVT Management and Outcome Trends, 2001 to 2014
39. Extended duration of anticoagulation with edoxaban in patients with venous thromboembolism: a post-hoc analysis of the Hokusai-VTE study
40. Recurrent venous thromboembolism and abnormal uterine bleeding with anticoagulant and hormone therapy use
41. Association between inflammation biomarkers, anatomic extent of deep venous thrombosis, and venous symptoms after deep venous thrombosis
42. External validation of a claims-based and clinical approach for predicting post-pulmonary embolism outcomes among United States veterans
43. Hospital length-of-stay and costs among pulmonary embolism patients treated with rivaroxaban versus parenteral bridging to warfarin
44. The risk of major bleeding in patients with Factor V Leiden or Prothrombin G20210A gene mutation while on extended anticoagulant treatment for VTE
45. Redefining clinical venous thromboembolism phenotypes: a novel approach using latent class analysis
46. A Prospective Study of Apixaban for Central Venous Catheter Associated Upper Extremity Deep Vein Thrombosis in Cancer Patients: Catheter 3
47. Performance of D-Dimers in Patients with Prior History of Venous Thromboembolism Based on Anticoagulation Status
48. Blood Biomarkers for the Prediction of Venous Thromboembolism in Perioperative or Hospitalized Cancer Patients: A Systematic Review
49. Thrombophilia Gene Mutations for the Prediction of Venous Thromboembolism in Ambulatory Cancer Patients Receiving Chemotherapy
50. Antepartum dalteparin versus no antepartum dalteparin for the prevention of pregnancy complications in pregnant women with thrombophilia (TIPPS): a multinational open-label randomised trial
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.